[1]
“DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES”, Int. Res. J. Pharm., vol. 2, no. 11, pp. 125–126, Nov. 2011, Accessed: Jul. 26, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/2988